Remdesivir News and Research

RSS
Researchers explore SARS-CoV-2 at single cell resolution in human airway epithelial cells

Researchers explore SARS-CoV-2 at single cell resolution in human airway epithelial cells

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Template for COVID-19 management in a rural health system

Template for COVID-19 management in a rural health system

Comparative analysis reveals common vulnerabilities across coronaviruses

Comparative analysis reveals common vulnerabilities across coronaviruses

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

Scientists discover a novel antiviral strategy for treating COVID-19

Scientists discover a novel antiviral strategy for treating COVID-19

COVID-19 can cause sudden permanent hearing loss in rare cases

COVID-19 can cause sudden permanent hearing loss in rare cases

Many coronavirus strains found in animals can also infect humans, shows study

Many coronavirus strains found in animals can also infect humans, shows study

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

Genoscience Pharma's GNS561 shows potential against SARS-CoV-2 in vitro

Genoscience Pharma's GNS561 shows potential against SARS-CoV-2 in vitro

Suramin shows promise as COVID-19 treatment

Suramin shows promise as COVID-19 treatment

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

NIH clinical trial to test a combination treatment regimen for COVID-19

NIH clinical trial to test a combination treatment regimen for COVID-19

Sofosbuvir combined with other antivirals is more effective against COVID-19, shows study

Sofosbuvir combined with other antivirals is more effective against COVID-19, shows study

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

Study confirms SARS-CoV-2 spike glycoprotein promotes a hyper-inflammatory immune response

Study confirms SARS-CoV-2 spike glycoprotein promotes a hyper-inflammatory immune response

Researchers develop research model to understand the impact of coronavirus on lungs

Researchers develop research model to understand the impact of coronavirus on lungs